ESR1 and breast cancer: In our study, AR reactivity was seen mainly in pure apocrine carcinomas or carcinomas with apocrine or histiocytoid features which is compatible with the findings reported by other investigators that molecular apocrine breast cancer is negative for ER and usually expresses AR and FOXA14,33,34.